Medical Oncologist
Cetuximab treatment duration
How Long Will You Stay on — Cetuximab?
Cetuximab is not given for a set number of rounds. In most settings, you continue for as long as it is working and your body is tolerating it. The question is not how many cycles — it is what stops treatment.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- No fixed end date — In most settings, cetuximab continues for as long as it is working and you can tolerate it.
- Three clear stopping rules — Treatment stops when the tumour grows, when side effects become unmanageable, or when a defined course ends.
- Regular scans decide — Imaging at intervals — not a calendar — is what your team uses to decide whether to keep going.
- You have a say — You can ask to stop at any point. Your oncologist will explain what that means for your situation.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Cetuximab has no fixed number of cycles in most settings. NCCN guidance treats it as a continuing treatment until the tumour stops responding, side effects become unacceptable, or you finish a defined course. When given alongside radiation for head and neck cancer, the course ends when radiation ends.
Why doesn't cetuximab have a fixed number of cycles?
Unlike many chemotherapy regimens, cetuximab is not given for a set number of rounds and then stopped. NCCN guidance recommends continuing it for as long as the tumour is responding and the side effects are manageable.
The logic is simple. Stopping a treatment that is still working makes no sense, and continuing one that has stopped working carries risk without benefit. So your oncologist watches the tumour, not a calendar.
The exception is when cetuximab is given with radiation to treat head and neck cancer with curative intent. There, it runs for the length of the radiation course and stops when radiation ends.
What actually stops cetuximab treatment?
Treatment stops when the tumour starts to grow again or spreads to new sites. This is called disease progression, and at that point cetuximab is no longer doing the job it was prescribed for.
It also stops if side effects become severe enough that continuing is not safe. A serious skin reaction or infusion reaction that does not settle with dose adjustment is the most common reason.
You can also ask to stop at any point. Your oncologist will explain what continuing or stopping is expected to mean for you, and that conversation is one you are entitled to have.
How does your team know cetuximab is still working?
Response is assessed through imaging — usually a CT scan, and sometimes a PET-CT — at intervals your team sets at the start of treatment.
They are looking for the tumour to shrink, stabilise, or at least not grow. Stabilisation — no change in size — counts as a response in many settings.
If you notice new symptoms between scan dates, tell your team rather than waiting for the next planned assessment. New symptoms do not necessarily mean progression, but your team needs to know.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What happens at each stage of treatment
Loading dose
Your first infusion is a higher dose than the ones that follow. It is given to reach the blood level the treatment needs to work.
Weekly infusions begin
After the loading dose, cetuximab is given weekly as an intravenous drip. Each session takes a portion of your day, and you go home the same day as your infusion.
Side effect monitoring
Your team checks your skin, magnesium levels and overall fitness at each visit. Skin reactions are common and are graded to decide whether to adjust the dose.
Response assessment scan
Imaging is arranged at regular intervals to check how the tumour is responding. Your team will tell you when to expect your first scan after starting treatment.
Continue, adjust or stop
Based on scan results and how you are tolerating treatment, your oncologist decides the next step — continuing as planned, reducing the dose, or stopping.
Did you know?
A skin rash from cetuximab — acneiform spots on the face, neck and chest — is associated with better treatment response across several cancer types.
ASCO guidance notes this pattern and uses it to inform how to manage the rash: a mild reaction is a signal to treat carefully and continue, not to stop.
Source: ASCO Clinical Practice Guidance — Management of EGFR Inhibitor Toxicities
Questions about how long treatment lasts
Can cetuximab work for years?
For some patients, cetuximab is continued for a prolonged period as long as the disease remains controlled and the side effects are manageable. This is not the experience of every patient, but it is not unusual either. Your oncologist will discuss what a long-term plan looks like in your case, including how often you will have scans and what milestones would prompt a change in approach.
What if I need a break from treatment?
Dose delays and temporary stops are a normal part of managing cetuximab, usually because of a skin reaction or a low magnesium level that needs to correct first. Your team will tell you when it is safe to restart. Missing one infusion rarely changes the overall outcome, but the decision to pause always comes from your oncologist based on your blood results and how your skin looks — not from guessing at home.
What comes next if cetuximab stops working?
When cetuximab stops controlling your cancer, your oncologist will look at what other treatments may be suitable. The options depend on your cancer type, what you have already had, your current fitness, and any new changes in the tumour's biology. For colorectal cancer, NCCN and ESMO guidance recognises several second-line options. Ask your oncologist what the plan is if the next scan shows progression — knowing the path ahead before you need it is a reasonable thing to want.
Will my dose change over time?
Dose reductions are a standard part of managing cetuximab. If you develop a severe skin reaction, your team may reduce the dose or pause treatment to let your skin recover, then restart at a lower level. This does not mean treatment has failed — it means it is being adjusted so you can continue for longer. ASCO guidance gives detailed criteria for these decisions, and your oncologist follows those criteria rather than making them ad hoc.
Can cetuximab be restarted after stopping?
In some cases, yes. If treatment was stopped because of side effects that have now resolved, your oncologist may consider restarting. If it was stopped because the cancer stopped responding, restarting the same treatment rarely works, because the tumour has already shown it is no longer sensitive. Whether a re-challenge makes sense depends on exactly why treatment stopped and what has changed since — that is a question to put directly to your oncologist.
Does the cancer always become resistant to cetuximab?
In many patients, cetuximab eventually stops working as the tumour adapts. This is called acquired resistance and is common with EGFR-targeted treatments. It does not happen on the same timeline for everyone, and some patients remain in good disease control for a prolonged period. Research is ongoing into what happens at the molecular level when resistance develops. Your oncologist is the right person to discuss what the current evidence says for your specific cancer type and how your team plans to monitor for it.
Explore 100 more Gastrointestinal & Liver Targeted Medicines topics
Drug Deep Dive: Cetuximab (Erbitux)
- Cetuximab (Erbitux): The Complete Patient Guide
- Cetuximab Infusion Day: Premedication, Duration and What to Expect
- Cetuximab Infusion Reactions: Why the First Dose Is Given Slowly
- Cetuximab Myths: 'The Worse the Rash, the Better' and Other Half-Truths
- Cetuximab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Cetuximab Side Effects: The Complete List and Timeline
- Cetuximab Success Rate and Survival: An Honest Look at the Numbers
- Cetuximab With FOLFIRI, FOLFOX and Radiation
- Cetuximab in Colorectal vs Head and Neck Cancer: Different Roles
- Cetuximab in Elderly Patients and Those With Other Illnesses
- Cetuximab vs Bevacizumab in Colorectal Cancer: Which and When
- Diet and Nutrition While on Cetuximab
- Drug, Food and Supplement Interactions With Cetuximab
- Fertility, Pregnancy and Contraception on Cetuximab
- How Does Cetuximab Work? The Anti-EGFR Monoclonal Antibody Explained
- How Long Does Cetuximab Take to Work?
- How Long Will You Stay on Cetuximab?
- Low Magnesium on Cetuximab: Cramps, Fatigue and Monthly Testing
- Tests and Monitoring While You Are on Cetuximab
- The Cetuximab Rash: Severity, Treatment and Why It Predicts Response
- When Cetuximab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Cetuximab? RAS Wild-Type Colorectal Cancer and Head and Neck Cancer
- Why Cetuximab Only Works in RAS Wild-Type, Left-Sided Tumours
- Will Insurance or a Government Scheme Pay for Cetuximab?
- Work, Travel and Daily Life on Cetuximab
Drug Deep Dive: Bevacizumab (Avastin)
- Avastin vs Biosimilar Bevacizumab in India: Cost and Safety
- Bevacizumab (Avastin and biosimilars): The Complete Patient Guide
- Bevacizumab Infusion Day: Premedication, Duration and What to Expect
- Bevacizumab Myths: 'It Dissolves Tumours' and Other Misconceptions
- Bevacizumab Price in India: Innovator, Biosimilar and Cost Per Cycle
- Bevacizumab Side Effects: The Complete List and Timeline
- Bevacizumab Success Rate and Survival: An Honest Look at the Numbers
- Bevacizumab With Chemotherapy: Which Combinations and Why
- Bevacizumab in Elderly Patients and Those With Other Illnesses
- Bevacizumab in Eye Disease vs Cancer: Same Drug, Very Different Dose
- Bleeding, Bowel Perforation and Wound Healing Risks on Bevacizumab
- Diet and Nutrition While on Bevacizumab
- Drug, Food and Supplement Interactions With Bevacizumab
- Fertility, Pregnancy and Contraception on Bevacizumab
- High Blood Pressure on Bevacizumab: Monitoring and Treatment
- How Does Bevacizumab Work? The Anti-VEGF Angiogenesis Inhibitor Explained
- How Long Does Bevacizumab Take to Work?
- How Long Will You Stay on Bevacizumab?
- Protein in Your Urine on Bevacizumab: What the Report Means
- Surgery While on Bevacizumab: The 28-Day Rule
- Tests and Monitoring While You Are on Bevacizumab
- When Bevacizumab Stops Working: Resistance and What Comes Next
- Who Is Eligible for Bevacizumab? Colorectal, Lung, Ovarian, Cervical and Brain Cancer
- Will Insurance or a Government Scheme Pay for Bevacizumab?
- Work, Travel and Daily Life on Bevacizumab
Drug Deep Dive: Lenvatinib (Lenvima)
- Blood Pressure Spikes on Lenvatinib: The Critical First Two Weeks
- Diarrhoea, Appetite Loss and Rapid Weight Drop on Lenvatinib
- Diet and Nutrition While on Lenvatinib
- Dose Reductions on Lenvatinib: Why Most Patients Need One
- Drug, Food and Supplement Interactions With Lenvatinib
- Fertility, Pregnancy and Contraception on Lenvatinib
- Hand-Foot Skin Reaction on Lenvatinib: Prevention and Relief
- How Does Lenvatinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Lenvatinib Take to Work?
- How Long Will You Stay on Lenvatinib?
- Lenvatinib (Lenvima, Lenvanix): The Complete Patient Guide
- Lenvatinib Myths: Side Effects, Dose Cuts and 'Giving Up'
- Lenvatinib Price in India: Brand, Generic and Monthly Cost
- Lenvatinib Side Effects: The Complete List and Timeline
- Lenvatinib Success Rate and Survival: An Honest Look at the Numbers
- Lenvatinib With Immunotherapy: The Combination Explained
- Lenvatinib for Radioactive-Iodine-Refractory Thyroid Cancer
- Lenvatinib in Elderly Patients and Those With Other Illnesses
- Lenvatinib vs Sorafenib for Liver Cancer: Which Comes First?
- Taking Lenvatinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Lenvatinib
- When Lenvatinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Lenvatinib? Liver, Thyroid, Kidney and Endometrial Cancer
- Will Insurance or a Government Scheme Pay for Lenvatinib?
- Work, Travel and Daily Life on Lenvatinib
Drug Deep Dive: Sorafenib (Nexavar)
- Blood Pressure, Rash and Hair Thinning on Sorafenib
- Diarrhoea on Sorafenib: Controlling It Without Stopping Treatment
- Diet and Nutrition While on Sorafenib
- Drug, Food and Supplement Interactions With Sorafenib
- Fertility, Pregnancy and Contraception on Sorafenib
- Hand-Foot Skin Reaction on Sorafenib: Prevention From Day One
- How Does Sorafenib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sorafenib Take to Work?
- How Long Will You Stay on Sorafenib?
- Sorafenib (Nexavar, Soranib): The Complete Patient Guide
- Sorafenib Myths: Dose Reduction, 'Last Resort' and Generic Quality
- Sorafenib Price in India: Brand, Generic and Monthly Cost
- Sorafenib Side Effects: The Complete List and Timeline
- Sorafenib Success Rate and Survival: An Honest Look at the Numbers
- Sorafenib With Cirrhosis: Why Child-Pugh Status Decides Eligibility
- Sorafenib With TACE and Other Liver-Directed Treatments
- Sorafenib in Elderly Patients and Those With Other Illnesses
- Sorafenib in Liver, Kidney and Thyroid Cancer: Three Different Uses
- Sorafenib vs Lenvatinib for Liver Cancer: Cost, Tolerability and Evidence
- Taking Sorafenib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sorafenib
- When Sorafenib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sorafenib? Liver, Kidney and Radioiodine-Refractory Thyroid Cancer
- Will Insurance or a Government Scheme Pay for Sorafenib?
- Work, Travel and Daily Life on Sorafenib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
How many infusions is a typical course of cetuximab?
There is no standard number, and that is the honest answer rather than a vague one. Unlike most chemotherapy regimens, cetuximab is not prescribed for a set number of cycles. Treatment continues for as long as the disease is responding and the side effects are tolerable. The number of infusions any person receives depends entirely on how long both of those conditions hold. Asking your oncologist what they expect at your next scan is a more useful question than asking for a total count.
What if I miss an infusion?
Missing one infusion occasionally is unlikely to change your overall outcome, but it should not become a pattern. Let your team know as soon as possible if you cannot make a scheduled appointment. They may reschedule it for the following week or adjust the plan slightly. Do not decide on your own to skip or delay — the timing is set for a clinical reason, and your team needs to know what is happening so they can guide you.
How will I know if it stops working before the next scan?
New symptoms between scans — a new lump, unexplained pain, weight loss, or a change you cannot explain — are always worth reporting to your team rather than waiting. They do not necessarily mean the treatment has stopped working, but your team needs to assess them. Scans are the most reliable way to know, which is why they are scheduled at regular intervals. If your team thinks a symptom warrants an earlier scan, they will arrange one.
Can I travel or take a holiday during cetuximab treatment?
In most cases, yes — the timing just needs planning. Cetuximab is given weekly, so a short trip between infusions is usually manageable. A longer trip may need your infusions to be temporarily arranged at another centre, which requires coordination between teams. Tell your oncologist well in advance so they can help organise it. The main concern is making sure you have access to medical care if a side effect develops away from home.
Does cetuximab stop working for everyone eventually?
Acquired resistance — where the tumour adapts and stops responding — is common with EGFR-targeted treatments like cetuximab, but it does not happen on the same timeline for everyone, and some patients remain in good disease control for a prolonged period. Whether and when it happens for you is something your oncologist monitors through regular scans. The evidence on how to manage resistance, and whether any approach can delay or overcome it, is an active area of research.
What does disease progression mean in practice?
Progression means the scan shows the tumour has grown beyond a defined threshold, or that cancer has appeared in new sites. The threshold is not arbitrary — RECIST criteria, used internationally, give oncologists a standardised way to measure and compare results over time. Progression does not mean all treatment has failed; it means cetuximab specifically is no longer doing enough and that a different approach needs to be considered. Your oncologist will explain what your scan showed and what the options are.